CAS 121032-29-9 Nelarabine - Analytical Products / Alfa Chemistry

CAT	AP121032299
CAS	121032-29-9
Structure
Molecular Weight	297.27

Description	≥98% (HPLC)
Solubility	H2O: 5 mg/mL, clear (warmed)
Assay	≥98% (HPLC)
Color	white to beige
Form	powder
Size	10MG, 50MG
Storage Conditions	2-8°C

1

Hyper-CVAD Plus Nelarabine in Newly Diagnosed Adult T-cell Acute Lymphoblastic Leukemia and T-lymphoblastic Lymphoma

Yasmin Abaza, Hagop M Kantarjian, Stefan Faderl, Elias Jabbour, Nitin Jain, Deborah Thomas, Tapan Kadia, Gautam Borthakur, Joseph D Khoury, Jan Burger, William Wierda, Susan O'Brien, Marina Konopleva, Alessandra Ferrajoli, etc.

Am J Hematol. 2018 Jan;93(1):91-99.

PMID: 29047158

1

Nelarabine in the Treatment of Pediatric and Adult Patients With T-cell Acute Lymphoblastic Leukemia and Lymphoma

Tapan M Kadia, Varsha Gandhi

Expert Rev Hematol. 2017 Jan;10(1):1-8.

PMID: 27869523

1

Relapsed T Cell ALL: Current Approaches and New Directions

Christine M McMahon, Selina M Luger

Curr Hematol Malig Rep. 2019 Apr;14(2):83-93.

PMID: 30880359

1

Safe Integration of Nelarabine Into Intensive Chemotherapy in Newly Diagnosed T-cell Acute Lymphoblastic Leukemia: Children's Oncology Group Study AALL0434

Stuart S Winter, Kimberly P Dunsmore, Meenakshi Devidas, Nancy Eisenberg, Barbara L Asselin, Brent L Wood, Marcia S Leonard Rn, John Murphy, Julie M Gastier-Foster, Andrew J Carroll, Nyla A Heerema, Mignon L Loh, etc.

Pediatr Blood Cancer. 2015 Jul;62(7):1176-83.

PMID: 25755211

1

The Role of Nelarabine in the Treatment of T-cell Acute Lymphoblastic Leukemia: Literature Review and Own Experience

Y Y Dyakonova, O I Bydanov, A M Popov, Y V Olshanskaya, E G Boichenko, O V Aleynikova, M A Maschan, L N Shelikhova, D V Litvinov, L A Khachatryan, N I Ponomareva, L G Fechina, G A Novichkova, E D Pashanov, etc.

Ter Arkh. 2018 Aug 17;90(7):38-50.

PMID: 30701921

* Products or Services Interested: Nelarabine (121032-29-9)
* Your question
* Name
* Email
Verification Code